KFS
NVAX icon

Kelly Financial Services’s Novavax NVAX Stock Holding History

Kelly Financial Services’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-110
Closed -$1.39K – 534
2024
Q2 		$1.39K Hold
110
– – ﹤0.01% 626
2024
Q1 		$526 Hold
110
– – ﹤0.01% 718
2023
Q4 		$528 Hold
110
– – ﹤0.01% 696
2023
Q3 		$796 Buy
+110
New +$879 ﹤0.01% 650

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Kelly Financial Services's NVAX Position: Q3 2024 in Review

Kelly Financial Services sold out of Novavax (NVAX) in Q3 2024, closing a stake of 110 shares — an estimated $1.39K sold.

Kelly Financial Services first reported a position in NVAX in Q3 2023 and held it in 4 quarters. The position peaked at $1.39K in Q2 2024. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

  • Kelly Financial Services reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 110 Novavax shares in Q3 2024, an estimated $1.39K.
  • Kelly Financial Services first reported a position in Novavax in Q3 2023 and held it in 4 quarters.
  • Kelly Financial Services's Novavax position peaked at $1.39K in Q2 2024.
  • 237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.